Literature DB >> 19344253

Mitochondrial function, morphology, and axonal transport in amyotrophic lateral sclerosis.

Jordi Magrané1, Giovanni Manfredi.   

Abstract

Perturbation of organellar axonal transport is increasingly recognized as an important contributor in a number of neurodegenerative diseases. Although the specificity of this impairment remains to be elucidated, growing evidence suggests that in certain disease conditions, mitochondria are affected primarily by transport defects. Many hypotheses have been formulated to explain the pathogenic mechanisms involved in amyotrophic lateral sclerosis (ALS). The mutations described so far in genetic forms of ALS (familial ALS, fALS) affect proteins involved in a wide variety of cellular mechanisms, including free radical scavenging, energy metabolism, axonal transport, RNA processing, DNA repair, vesicular transport, and angiogenesis. Here we review the current knowledge on mitochondrial transport and its role in ALS.

Entities:  

Mesh:

Year:  2009        PMID: 19344253      PMCID: PMC2789440          DOI: 10.1089/ARS.2009.2604

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  118 in total

1.  Movement of mitochondria in the axons and dendrites of cultured hippocampal neurons.

Authors:  L A Ligon; O Steward
Journal:  J Comp Neurol       Date:  2000-11-20       Impact factor: 3.215

2.  Role of microtubules and actin filaments in the movement of mitochondria in the axons and dendrites of cultured hippocampal neurons.

Authors:  L A Ligon; O Steward
Journal:  J Comp Neurol       Date:  2000-11-20       Impact factor: 3.215

3.  Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death.

Authors:  G M Borthwick; M A Johnson; P G Ince; P J Shaw; D M Turnbull
Journal:  Ann Neurol       Date:  1999-11       Impact factor: 10.422

Review 4.  A fuzzy mitochondrial fusion apparatus comes into focus.

Authors:  Amy D Mozdy; Janet M Shaw
Journal:  Nat Rev Mol Cell Biol       Date:  2003-06       Impact factor: 94.444

Review 5.  The glamour and gloom of glycogen synthase kinase-3.

Authors:  Richard S Jope; Gail V W Johnson
Journal:  Trends Biochem Sci       Date:  2004-02       Impact factor: 13.807

6.  A direct interaction between cytoplasmic dynein and kinesin I may coordinate motor activity.

Authors:  Lee A Ligon; Mariko Tokito; Jeffrey M Finklestein; Francesca E Grossman; Erika L F Holzbaur
Journal:  J Biol Chem       Date:  2004-02-24       Impact factor: 5.157

7.  The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids.

Authors:  D Liu; J Wen; J Liu; L Li
Journal:  FASEB J       Date:  1999-12       Impact factor: 5.191

8.  Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

Authors:  Lindsey R Fischer; Deborah G Culver; Philip Tennant; Albert A Davis; Minsheng Wang; Amilcar Castellano-Sanchez; Jaffar Khan; Meraida A Polak; Jonathan D Glass
Journal:  Exp Neurol       Date:  2004-02       Impact factor: 5.330

Review 9.  Mitochondrial movement and positioning in axons: the role of growth factor signaling.

Authors:  Sonita R Chada; Peter J Hollenbeck
Journal:  J Exp Biol       Date:  2003-06       Impact factor: 3.312

10.  Levels of human Fis1 at the mitochondrial outer membrane regulate mitochondrial morphology.

Authors:  Diana Stojanovski; Olga S Koutsopoulos; Koji Okamoto; Michael T Ryan
Journal:  J Cell Sci       Date:  2004-03-01       Impact factor: 5.285

View more
  49 in total

1.  SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouse.

Authors:  Lindsey R Fischer; Anissa Igoudjil; Jordi Magrané; Yingjie Li; Jason M Hansen; Giovanni Manfredi; Jonathan D Glass
Journal:  Brain       Date:  2010-11-14       Impact factor: 13.501

Review 2.  Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.

Authors:  Ying Liu; Wenbin Deng
Journal:  Brain Res       Date:  2015-09-28       Impact factor: 3.252

3.  Cargo distributions differentiate pathological axonal transport impairments.

Authors:  Cassie S Mitchell; Robert H Lee
Journal:  J Theor Biol       Date:  2012-01-25       Impact factor: 2.691

Review 4.  Mitochondrial dysfunction in amyotrophic lateral sclerosis.

Authors:  Ping Shi; Jozsef Gal; David M Kwinter; Xiaoyan Liu; Haining Zhu
Journal:  Biochim Biophys Acta       Date:  2009-08-26

5.  Endolysosomal Deficits Augment Mitochondria Pathology in Spinal Motor Neurons of Asymptomatic fALS Mice.

Authors:  Yuxiang Xie; Bing Zhou; Mei-Yao Lin; Shiwei Wang; Kevin D Foust; Zu-Hang Sheng
Journal:  Neuron       Date:  2015-07-15       Impact factor: 17.173

6.  Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1α.

Authors:  Wenjun Song; Yuting Song; Brad Kincaid; Blaise Bossy; Ella Bossy-Wetzel
Journal:  Neurobiol Dis       Date:  2012-07-20       Impact factor: 5.996

Review 7.  Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis.

Authors:  Wenzhi Tan; Piera Pasinelli; Davide Trotti
Journal:  Biochim Biophys Acta       Date:  2014-02-22

8.  Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities.

Authors:  Jordi Magrané; Isabel Hervias; Matthew S Henning; Maria Damiano; Hibiki Kawamata; Giovanni Manfredi
Journal:  Hum Mol Genet       Date:  2009-09-24       Impact factor: 6.150

9.  ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2.

Authors:  Steve Pedrini; Daniela Sau; Stefania Guareschi; Marina Bogush; Robert H Brown; Nicole Naniche; Azadeh Kia; Davide Trotti; Piera Pasinelli
Journal:  Hum Mol Genet       Date:  2010-05-11       Impact factor: 6.150

10.  A mutation in Drosophila Aldolase causes temperature-sensitive paralysis, shortened lifespan, and neurodegeneration.

Authors:  Daniel Miller; Colleen Hannon; Barry Ganetzky
Journal:  J Neurogenet       Date:  2012-08-13       Impact factor: 1.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.